← Back to Patent Explorer
US4115555A Expired / Lapsed US ⏱️ 0.0 years remaining

2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones

Assignee: ER Squibb and Sons LLC
•
Filing: 1977-07-05
•
Granted: 1978-09-19
•
Expires: 1997-07-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the following formula ##STR1## wherein R 1 and R 2 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, nitro, cyano, and trifluoromethyl, and R is selected from a triacetyl substituted pentose, pentose, a tetraacetyl substituted hexose, hexose, a hydroxy substituted cycloalkyl of 5 to 7 carbons, ##STR2## wherein n is 1 or 2 ad R 3 is hydrogen, an alkali metal or alkaline earth metal ion; are disclosed. These compounds possess useful anti-inflammatory activity.

Inventors

  • 👤 Peter C. Wade
  • 👤 Berthold Richard Vogt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 04:01
CPC Classifications
C; C07; C07D; C07D221/00; C07D221/02; C07D221/04; C07D221/06; C07D221/14; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/048

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 50 words
A compound of the formula: ##STR16## wherein R 1 and R 2 are independently selected from the group consisting of hydrogen, lower alkyl, lower alkoxy, halogen, lower alkylthio, nitro, cyano, and trifluoromethyl; and R is selected from the group consisting of triacetyl substituted pentose, pentose, tetraacetyl substituted hexose, and hexose.
Claim 2
Dependent Claim 50 words
A compound of the formula: ##STR16## wherein R 1 and R 2 are independently selected from the group consisting of hydrogen, lower alkyl, lower alkoxy, halogen, lower alkylthio, nitro, cyano, and trifluoromethyl; and R is selected from the group consisting of triacetyl substituted pentose, pentose, tetraacetyl substituted hexose, and hexose.
Claim 3
Dependent Claim 43 words
The compound of claim 1 having the formula: ##STR17## wherein R 1 and R 2 are independently selected from the group consisting of hydrogen, Cl, Br, F, methyl and methoxy and are located at the 7- or 8-position and 5- or 6-position respectively.
Claim 4
Dependent Claim 39 words
The compound of claim 2 wherein said pentose is selected from the group consisting of D-ribose, D-arabinose, D-xylose, and D-lyxose and said hexose is selected from the group consisting of D-glucose, D-allose, D-gulose, D-galactose, D-altrose, D-mannose, D-idose, and D-talose.
Claim 5
Dependent Claim 22 words
The compound of claim 3 wherein R is D-glucose or tetraacetyl substituted D-glucose and R 1 and R 2 are both hydrogen.
Claim 6
Dependent Claim 8 words
The compound of claim 4, 2-β-D-glucosyl-1H-benz[de]isoquinoline-1,3(2H)-dione, tetraacetate ester.
Claim 7
Dependent Claim 6 words
The compound of claim 4, 2-β-D-glucosyl-1H-benz[de]isoquinoline-1,3(2H)-dione.
Claim 8
Dependent Claim 39 words
A pharmaceutical composition useful for treating inflammation in a mammalian specie comprising as the active ingredient from about 1 mg./kg. to about 30 mg./kg. of a compound or mixture of compounds of claim 1 and a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 20 words
The method of treating inflammation in a mammalian specie comprising administering an effective amount of the composition of claim 7.

References Cited (Backward Citations)

US3247208A Cited
US3876642A Cited
US3939093A Cited
US3935227A Cited
US3940397A Cited
US3947452A Cited
US3959286A Cited
US3940398A Cited
US3996362A Cited
US3996363A Cited
US4006238A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-09-18 1982-03-20 1982-09-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-09-18 1986-03-20 1986-09-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-09-18 1990-03-20 1990-09-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag